Rockefeller Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-22,246
| Closed | -$314K | – | 1731 |
|
|
2024
Q1 | $314K | Buy |
+22,246
| New | +$314K | ﹤0.01% | 1582 |
|
|
2023
Q1 | – | Sell |
-16,356
| Closed | -$148K | – | 3699 |
|
|
2022
Q4 | $148K | Buy |
16,356
+2,355
| +17% | +$21.3K | ﹤0.01% | 1816 |
|
|
2022
Q3 | $112K | Sell |
14,001
-12,751
| -48% | -$102K | ﹤0.01% | 1933 |
|
|
2022
Q2 | $200K | Buy |
26,752
+336
| +1% | +$2.51K | ﹤0.01% | 1635 |
|
|
2022
Q1 | $247K | Hold |
26,416
| – | – | ﹤0.01% | 1605 |
|
|
2021
Q4 | $211K | Buy |
26,416
+6,833
| +35% | +$54.6K | ﹤0.01% | 1625 |
|
|
2021
Q3 | $190K | Buy |
19,583
+7,385
| +61% | +$71.7K | ﹤0.01% | 1603 |
|
|
2021
Q2 | $120K | Buy |
12,198
+10,228
| +519% | +$101K | ﹤0.01% | 1712 |
|
|
2021
Q1 | $22K | Hold |
1,970
| – | – | ﹤0.01% | 2243 |
|
|
2020
Q4 | $18K | Buy |
1,970
+222
| +13% | +$2.03K | ﹤0.01% | 2056 |
|
|
2020
Q3 | $15K | Sell |
1,748
-347
| -17% | -$2.98K | ﹤0.01% | 1893 |
|
|
2020
Q2 | $26K | Sell |
2,095
-8,165
| -80% | -$101K | ﹤0.01% | 1594 |
|
|
2020
Q1 | $92K | Buy |
10,260
+250
| +2% | +$2.24K | ﹤0.01% | 1040 |
|
|
2019
Q4 | $98K | Buy |
10,010
+8,861
| +771% | +$86.8K | ﹤0.01% | 979 |
|
|
2019
Q3 | $8K | Sell |
1,149
-102
| -8% | -$710 | ﹤0.01% | 1500 |
|
|
2019
Q2 | $11K | Sell |
1,251
-434
| -26% | -$3.82K | ﹤0.01% | 1209 |
|
|
2019
Q1 | $27K | Buy |
1,685
+663
| +65% | +$10.6K | ﹤0.01% | 1128 |
|
|
2018
Q4 | $16K | Sell |
1,022
-400
| -28% | -$6.26K | ﹤0.01% | 651 |
|
|
2018
Q3 | $31K | Hold |
1,422
| – | – | ﹤0.01% | 473 |
|
|
2018
Q2 | $35K | Hold |
1,422
| – | – | ﹤0.01% | 477 |
|
|
2018
Q1 | $24K | Buy |
+1,422
| New | +$24K | ﹤0.01% | 462 |
|